Barker RA - Search Results

1

Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease.

Ye Z, Altena E, Nombela C, Housden CR, Maxwell H, Rittman T, Huddleston C, Rae CL, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB. Ye Z, et al. Among authors: barker ra. Brain. 2014 Apr;137(Pt 4):1145-55. doi: 10.1093/brain/awu032. Epub 2014 Feb 27. Brain. 2014. PMID: 24578545 Free PMC article. Clinical Trial.

2

Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.

Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM. Cools R, et al. Among authors: barker ra. Brain. 2002 Mar;125(Pt 3):584-94. doi: 10.1093/brain/awf052. Brain. 2002. PMID: 11872615

3

Verbal fluency in Huntington's disease: a longitudinal analysis of phonemic and semantic clustering and switching.

Ho AK, Sahakian BJ, Robbins TW, Barker RA, Rosser AE, Hodges JR. Ho AK, et al. Among authors: barker ra. Neuropsychologia. 2002;40(8):1277-84. doi: 10.1016/s0028-3932(01)00217-2. Neuropsychologia. 2002. PMID: 11931930 Free article.

4

The heterogeneity of idiopathic Parkinson's disease.

Foltynie T, Brayne C, Barker RA. Foltynie T, et al. Among authors: barker ra. J Neurol. 2002 Feb;249(2):138-45. doi: 10.1007/pl00007856. J Neurol. 2002. PMID: 11985378 Review.

5

Inhibition of subliminally primed responses is mediated by the caudate and thalamus: evidence from functional MRI and Huntington's disease.

Aron AR, Schlaghecken F, Fletcher PC, Bullmore ET, Eimer M, Barker R, Sahakian BJ, Robbins TW. Aron AR, et al. Brain. 2003 Mar;126(Pt 3):713-23. doi: 10.1093/brain/awg067. Brain. 2003. PMID: 12566291 Free PMC article.

6

Using executive heterogeneity to explore the nature of working memory deficits in Parkinson's disease.

Lewis SJ, Cools R, Robbins TW, Dove A, Barker RA, Owen AM. Lewis SJ, et al. Among authors: barker ra. Neuropsychologia. 2003;41(6):645-54. doi: 10.1016/s0028-3932(02)00257-9. Neuropsychologia. 2003. PMID: 12591022

7

Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study.

Pavese N, Andrews TC, Brooks DJ, Ho AK, Rosser AE, Barker RA, Robbins TW, Sahakian BJ, Dunnett SB, Piccini P. Pavese N, et al. Among authors: barker ra. Brain. 2003 May;126(Pt 5):1127-35. doi: 10.1093/brain/awg119. Brain. 2003. PMID: 12690052

8

L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease.

Cools R, Barker RA, Sahakian BJ, Robbins TW. Cools R, et al. Among authors: barker ra. Neuropsychologia. 2003;41(11):1431-41. doi: 10.1016/s0028-3932(03)00117-9. Neuropsychologia. 2003. PMID: 12849761 Clinical Trial.

9

Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry.

Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM. Lewis SJ, et al. Among authors: barker ra. J Neurosci. 2003 Jul 16;23(15):6351-6. doi: 10.1523/JNEUROSCI.23-15-06351.2003. J Neurosci. 2003. PMID: 12867520 Free PMC article. Clinical Trial.

10

A case of unilateral neglect in Huntington's disease.

Ho AK, Manly T, Nestor PJ, Sahakian BJ, Bak TH, Robbins TW, Rosser AE, Barker RA. Ho AK, et al. Among authors: barker ra. Neurocase. 2003 Jun;9(3):261-73. doi: 10.1076/neur.9.3.261.15559. Neurocase. 2003. PMID: 12925932

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

645 results

Search Page

Filters